Bellicum Pharmaceuticals, Inc. Share Price OTC Markets
Equities
BLCM
US0794814048
Biotechnology & Medical Research
Sales 2021 | 6.2M 496M | Sales 2022 | 1.5M 120M | Capitalization | 822K 65.83M |
---|---|---|---|---|---|
Net income 2021 | -9M -721M | Net income 2022 | -25M -2B | EV / Sales 2021 * | - |
Net cash position 2021 * | - 0 | Net cash position 2022 * | - 0 | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 * |
-
| Employees | 13 |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 98.45% |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |